515 related articles for article (PubMed ID: 16909065)
1. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK
Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity in chronic disabling occupational spinal disorders has minimal impact on functional restoration socioeconomic outcomes.
Dersh J; Mayer T; Gatchel RJ; Towns B; Theodore B; Polatin P
Spine (Phila Pa 1976); 2007 Aug; 32(17):1917-25. PubMed ID: 17762302
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric, behavioural and social risk factors for HIV infection among female drug users.
Gilchrist G; Blazquez A; Torrens M
AIDS Behav; 2011 Nov; 15(8):1834-43. PubMed ID: 21748277
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric symptoms, risky behavior, and HIV infection.
Woody GE; Metzger D; Navaline H; McLellan T; O'Brien CP
NIDA Res Monogr; 1997; 172():156-70. PubMed ID: 9154270
[TBL] [Abstract][Full Text] [Related]
6. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
7. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
8. Bipolar obsessive-compulsive disorder and personality disorders.
Maina G; Albert U; Pessina E; Bogetto F
Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
[TBL] [Abstract][Full Text] [Related]
10. Drug use and HIV risk practices of secondary and primary needle exchange users.
Huo D; Bailey SL; Hershow RC; Ouellet L
AIDS Educ Prev; 2005 Apr; 17(2):170-84. PubMed ID: 15899754
[TBL] [Abstract][Full Text] [Related]
11. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange.
Kidorf M; Solazzo S; Yan H; Brooner RK
J Dual Diagn; 2018; 14(4):193-200. PubMed ID: 30332349
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
Zimmermann P; Brückl T; Nocon A; Pfister H; Lieb R; Wittchen HU; Holsboer F; Angst J
Arch Gen Psychiatry; 2009 Dec; 66(12):1341-52. PubMed ID: 19996039
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric comorbidity and suicidality among intravenous drug users.
Dinwiddie SH; Reich T; Cloninger CR
J Clin Psychiatry; 1992 Oct; 53(10):364-9. PubMed ID: 1429476
[TBL] [Abstract][Full Text] [Related]
15. Needle exchange programs and drug infection behavior.
DeSimone J
J Policy Anal Manage; 2005; 24(3):559-77. PubMed ID: 15973795
[TBL] [Abstract][Full Text] [Related]
16. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
17. [The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements].
Håkansson AC
Lakartidningen; 2012 Jun 19-26; 109(25):1216-7. PubMed ID: 22838110
[No Abstract] [Full Text] [Related]
18. Epidemiology of psychiatric disorders in Edmonton. Antisocial personality disorders.
Swanson MC; Bland RC; Newman SC
Acta Psychiatr Scand Suppl; 1994; 376():63-70. PubMed ID: 8178687
[TBL] [Abstract][Full Text] [Related]
19. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
King VL; Kidorf MS; Stoller KB; Brooner RK
J Addict Dis; 2000; 19(4):65-83. PubMed ID: 11110066
[TBL] [Abstract][Full Text] [Related]
20. Antisocial personality disorder among drug abusers. Relations to other personality diagnoses and the five-factor model of personality.
Brooner RK; Herbst JH; Schmidt CW; Bigelow GE; Costa PT
J Nerv Ment Dis; 1993 May; 181(5):313-9. PubMed ID: 8501448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
